- Home
- NERV vs ILAG Comparison
NERV vs ILAG Comparison
Compare NERV & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- ILAG
- Stock Information
- Founded
- NERV 2007
- ILAG 1981
- Country
- NERV United States
- ILAG Hong Kong
- Employees
- NERV N/A
- ILAG N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- ILAG Office Equipment/Supplies/Services
- Sector
- NERV Health Care
- ILAG Consumer Discretionary
- Exchange
- NERV Nasdaq
- ILAG Nasdaq
- Market Cap
- NERV 15.5M
- ILAG 14.4M
- IPO Year
- NERV 2014
- ILAG 2022
- Fundamental
- Price
- NERV $1.82
- ILAG $0.83
- Analyst Decision
- NERV Hold
- ILAG
- Analyst Count
- NERV 1
- ILAG 0
- Target Price
- NERV $5.00
- ILAG N/A
- AVG Volume (30 Days)
- NERV 77.1K
- ILAG 12.4K
- Earning Date
- NERV 03-04-2025
- ILAG 04-14-2025
- Dividend Yield
- NERV N/A
- ILAG N/A
- EPS Growth
- NERV N/A
- ILAG N/A
- EPS
- NERV N/A
- ILAG N/A
- Revenue
- NERV N/A
- ILAG $8,980,747.00
- Revenue This Year
- NERV N/A
- ILAG N/A
- Revenue Next Year
- NERV N/A
- ILAG N/A
- P/E Ratio
- NERV N/A
- ILAG N/A
- Revenue Growth
- NERV N/A
- ILAG 33.03
- 52 Week Low
- NERV $1.77
- ILAG $0.35
- 52 Week High
- NERV $7.53
- ILAG $1.35
- Technical
- Relative Strength Index (RSI)
- NERV 34.70
- ILAG 49.70
- Support Level
- NERV $1.77
- ILAG $0.73
- Resistance Level
- NERV $2.05
- ILAG $0.84
- Average True Range (ATR)
- NERV 0.16
- ILAG 0.08
- MACD
- NERV -0.04
- ILAG 0.01
- Stochastic Oscillator
- NERV 6.41
- ILAG 79.70
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.